Lab
ST. Agnes Healthcare, INC.
ST. Agnes Healthcare, INC. was paid $891K by Medicaid between Jan 2018 and Dec 2024, across 62 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 22% of everything it billed.
33Billing provider infoST. AGNES HEALTHCARE, INC.
BALTIMORE, MD 21229
BALTIMORE, MD 21229
33aNPI1164462925assigned 06/08/2006
33bProvider typeClinical Medical Laboratory
28Total paid$891K
24GClaims89,107
24DCodes billed62
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Maryland
Rank by total paid#40 of 93
Median peer was paid$430K
This provider vs. median2.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 933 | $6K | |
| 2019 | 1,888 | $5K | |
| 2020 | 23,720 | $220K | |
| 2021 | 32,489 | $386K | |
| 2022 | 25,378 | $245K | |
| 2023 | 2,634 | $18K | |
| 2024incomplete | 2,065 | $11K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 22% | 2,708 | 2,485 | $195K |
| 80053 | Comprehensive metabolic panel | 7.4% | 9,948 | 9,057 | $66K |
| 80061 | Lipid panel | 6.9% | 6,343 | 5,934 | $61K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.7% | 10,352 | 9,302 | $51K |
| 84443 | Thyroid stimulating hormone (TSH) | 4.5% | 4,507 | 4,169 | $40K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.4% | 1,724 | 1,608 | $39K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.2% | 1,419 | 1,335 | $38K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.2% | 1,413 | 1,331 | $38K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.5% | 4,580 | 4,259 | $32K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.1% | 1,523 | 1,415 | $28K |
| 36415 | Collection of venous blood by venipuncture | 2.9% | 13,116 | 11,503 | $26K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.7% | 352 | 328 | $24K |
50 more codes
| 86803 | 2.5% | 2,017 | $22K | |
| 82728 | 1.7% | 1,510 | $15K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.6% | 358 | $14K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.5% | 130 | $13K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.4% | 1,922 | $13K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.3% | 1,937 | $12K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1.3% | 429 | $11K |
| 88142 | 1.3% | 715 | $11K | |
| 86780 | 1.3% | 1,125 | $11K | |
| 82607 | 1.2% | 1,053 | $11K | |
| 83550 | 1.1% | 1,589 | $10K | |
| 84153 | <1% | 701 | $9K | |
| 84439 | <1% | 1,322 | $9K | |
| 80050 | General health panel | <1% | 932 | $9K |
| 87088 | <1% | 1,317 | $8K | |
| 83540 | <1% | 1,645 | $8K | |
| 87660 | <1% | 424 | $6K | |
| 87510 | <1% | 424 | $6K | |
| 87480 | <1% | 423 | $6K | |
| 87340 | <1% | 699 | $5K | |
| 82746 | <1% | 585 | $5K | |
| 86850 | <1% | 1,058 | $5K | |
| 82043 | <1% | 1,160 | $5K | |
| 81001 | <1% | 1,674 | $4K | |
| 85730 | <1% | 723 | $3K | |
| 85610 | <1% | 1,050 | $3K | |
| 85027 | <1% | 577 | $3K | |
| 86900 | <1% | 1,072 | $2K | |
| 86901 | <1% | 1,073 | $2K | |
| 86481 | <1% | 27 | $2K | |
| 86140 | <1% | 248 | $920.27 | |
| 87186 | <1% | 139 | $905.09 | |
| 86038 | <1% | 93 | $755.26 | |
| 85652 | <1% | 347 | $682.60 | |
| 84403 | <1% | 31 | $648.83 | |
| 87077 | <1% | 97 | $559.71 | |
| 83735 | <1% | 98 | $472.38 | |
| 80074 | <1% | 12 | $461.69 | |
| 84703 | <1% | 74 | $450.95 | |
| 87070 | <1% | 61 | $376.55 | |
| 84550 | <1% | 83 | $307.48 | |
| 86317 | <1% | 25 | $290.09 | |
| 84402 | <1% | 13 | $276.88 | |
| 86696 | <1% | 14 | $224.20 | |
| 84270 | <1% | 12 | $212.76 | |
| 86695 | <1% | 15 | $178.54 | |
| 86762 | <1% | 13 | $162.49 | |
| 83655 | <1% | 12 | $143.38 | |
| 83615 | <1% | 38 | $135.43 | |
| 86431 | <1% | 26 | $124.90 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVANDER KOLK, KEITH (PRESIDENT/CEO)
Parent organizationST. AGNES HEALTHCARE, INC.
| Provider | Location | Paid |
|---|---|---|
| ST. Agnes Healthcare, INC. | Baltimore, MD | $5.36M |
| ST. Agnes Healthcare, INC. | Baltimore, MD | $21K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.